Maximus, Inc. Reports Q3 2025 Earnings: Revenue Grows Amid Cash Flow Challenges and Delays

Maximus, Inc. (NYSE: MMS) - Q3 2025 Financial Overview

Maximus, Inc. has reported its financial results for the third quarter ending June 30, 2025. The company, which provides essential government services, has shown both positive growth and areas of concern in its income statement.

Key Financial Highlights:

• Revenue: $1.35 billion, up 2.5% from $1.31 billion in Q3 2024.
• Gross Profit: $359.5 million, reflecting an 8.2% increase year-over-year.
• Net Income: $106.0 million, a 18.1% increase from $89.8 million in Q3 2024.
• Earnings Per Share (Diluted): $1.86, compared to $1.46 a year ago.
• Operating Income: $165.7 million, a 16.9% increase from $141.7 million in the same quarter last year.
• Cash Flow from Operations: Net cash used was $220 million, a significant drop from $351 million generated in the previous year.
• Accounts Receivable: Increased to $1.42 billion from $879 million, largely due to billing delays with clients.

Positive Aspects of Income Statement:

• Significant revenue growth driven by the U.S. Federal Services segment, particularly in clinical programs such as medical assessments.
• Improved gross profit margin to 26.7%, up from 25.3% in the previous year.
• Robust growth in operating income, showcasing better operational efficiency.

Negative Aspects of Income Statement:

• Substantial cash used in operations due to delays in billing and collections, particularly affecting the U.S. Federal and U.S. Services segments.
• Accounts receivable increased significantly, raising concerns about cash flow management.
• Interest expense increased to $22.7 million, from $20.6 million, driven by additional borrowings amid cash flow issues.

Operational Highlights:

• Continued delays in cash collections influenced by administrative delays in client billing processes.
• Recent divestitures in Australia and Korea, reflecting strategic adjustments in international operations.
• Future guidance remains cautiously optimistic with an anticipated correction in cash flow and collections.

Segment Performance:

• U.S. Federal Services saw revenue growth of 11% YoY, buoyed by increased clinical program activity.
• U.S. Services segment revenue dropped by 6.8% YoY, impacted by reduced Medicaid-related activities.
• Outside the U.S. segment also faced a decrease in revenue but noted a shift to profitability after recent divestitures.

Maximus is focusing on enhancing its operational efficiency as it navigates recent challenges while capitalizing on growth opportunities in government services. The company aims to stabilize cash flow in the upcoming fiscal period.